| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2021―Jun―28 |
Use of nanotechnology in combating coronavirus |
Saee Gharpure, Balaprasad Ankamwar |
| 2 |
[GO] |
2021―Apr―25 |
Mutational heterogeneity in spike glycoproteins of severe acute respiratory syndrome coronavirus 2 |
Aanchal Mathur, Sibi Raj, Niraj Kumar Jha, Saurabh Kumar Jha, Brijesh Rathi, Dhruv Kumar |
| 3 |
[GO] |
2021―Mar―27 |
A review of novel coronavirus disease (COVID-19): based on genomic structure, phylogeny, current shreds of evidence, candidate vaccines, and drug repurposing |
S. Udhaya Kumar, N. Madhana Priya, S. R. Nithya, Priyanka Kannan, Nikita Jain, D. Thirumal Kumar, et al. (+4) R. Magesh, Salma Younes, Hatem Zayed, C. George Priya Doss |
| 4 |
[GO] |
2021―Feb―22 |
Cordifolioside: potent inhibitor against Mpro of SARS-CoV-2 and immunomodulatory through human TGF-β and TNF-α |
Munikumar Manne, Giridhar Goudar, Seshadri Reddy Varikasuvu, Mahadev C. Khetagoudar, Hema Kanipakam, Pradeep Natarajan, et al. (+7) Muni Divya Ummiti, Vijay Aravind Yenagi, Sridhar Chinthakindi, Prakash Dharani, Durga Sai Sri Thota, Sameer Patil, Vijaylaxmi Patil |
| 5 |
[GO] |
2021―Feb―09 |
Screening of JAK-STAT modulators from the antiviral plants of Indian traditional system of medicine with the potential to inhibit 2019 novel coronavirus using network pharmacology |
Pukar Khanal, Taaza Duyu, B. M. Patil, Yadu Nandan Dey, Ismail Pasha, Rohini S. Kavalapure, et al. (+2) Sharad Chand, Shailendra Gurav |
| 6 |
[GO] |
2021―Feb―01 |
Structural analysis of COVID-19 spike protein in recognizing the ACE2 receptor of different mammalian species and its susceptibility to viral infection |
Tirthankar Koley, Shivani Madaan, Sanghati Roy Chowdhury, Manoj Kumar, Punit Kaur, Tej Pal Singh, Abdul S. Ethayathulla |
| 7 |
[GO] |
2021―Jan―25 |
Molecular mechanism, diagnosis, and potential treatment for novel coronavirus (COVID-19): a current literature review and perspective |
Yashwant Kumar Ratre, Namrata Kahar, L. V. K. S. Bhaskar, Antaripa Bhattacharya, Henu Kumar Verma |
| 8 |
[GO] |
2021―Jan―24 |
Screening of potent drug inhibitors against SARS-CoV-2 RNA polymerase: an in silico approach |
Sanjay Kumar Singh, Atul Kumar Upadhyay, M. Sudhakara Reddy |
| 9 |
[GO] |
2021―Jan―22 |
Perspective on therapeutic and diagnostic potential of camel nanobodies for coronavirus disease-19 (COVID-19) |
Salma Bessalah, Samira Jebahi, Naceur Mejri, Imed Salhi, Touhami Khorchani, Mohamed Hammadi |
| 10 |
[GO] |
2021―Jan―13 |
Factual insights of the allosteric inhibition mechanism of SARS-CoV-2 main protease by quercetin: an in silico analysis |
Shalja Verma, Anand Kumar Pandey |
| 11 |
[GO] |
2021―Jan―12 |
Smart technologies driven approaches to tackle COVID-19 pandemic: a review |
Hameed Khan, K. K. Kushwah, Saurabh Singh, Harshika Urkude, Muni Raj Maurya, Kishor Kumar Sadasivuni |
| 12 |
[GO] |
2021―Jan―12 |
In silico docking analysis revealed the potential of phytochemicals present in Phyllanthus amarus and Andrographis paniculata, used in Ayurveda medicine in inhibiting SARS-CoV-2 |
Shridhar Hiremath, H. D. Vinay Kumar, M. Nandan, M. Mantesh, K. S. Shankarappa, V. Venkataravanappa, et al. (+2) C. R. Jahir Basha, C. N. Lakshminarayana Reddy |
| 13 |
[GO] |
2021―Jan―12 |
Designing a next generation multi-epitope based peptide vaccine candidate against SARS-CoV-2 using computational approaches |
Ratnadeep Saha, Pratik Ghosh, V. L. S. Prasad Burra |
| 14 |
[GO] |
2021―Jan―09 |
Recent biotechnological advances as potential intervention strategies against COVID-19 |
Naun Lobo-Galo, Juan-Carlos Gálvez-Ruíz, Ana P. Balderrama-Carmona, Norma P. Silva-Beltrán, Eduardo Ruiz-Bustos |
| 15 |
[GO] |
2020―Nov―26 |
Probiotics in the prophylaxis of COVID-19: something is better than nothing |
Kushal Gohil, Rachel Samson, Syed Dastager, Mahesh Dharne |
| 16 |
[GO] |
2020―Nov―11 |
Immunotherapeutics for Covid-19 and post vaccination surveillance |
N. S. Sampath Kumar, Anjani Devi Chintagunta, S. P. Jeevan Kumar, Sharmili Roy, Mahesh Kumar |
| 17 |
[GO] |
2020―Oct―21 |
In silico analysis of ACE2 orthologues to predict animal host range with high susceptibility to SARS-CoV-2 |
El Mehdi Bouricha, Mohammed Hakmi, Jihane Akachar, Lahcen Belyamani, Azeddine Ibrahimi |
| 18 |
[GO] |
2020―Oct―19 |
Targeting complement cascade: an alternative strategy for COVID-19 |
Sureshbabu Ram Kumar Pandian, Sankarganesh Arunachalam, Venkataraman Deepak, Selvaraj Kunjiappan, Krishnan Sundar |
| 19 |
[GO] |
2020―Sep―16 |
An overview of COVID-19 with an emphasis on computational approach for its preventive intervention |
Divya Mishra, Ashish Mishra, Vivek K. Chaturvedi, M. P. Singh |
| 20 |
[GO] |
2020―Sep―10 |
Identification of potential mRNA panels for severe acute respiratory syndrome coronavirus 2 (COVID-19) diagnosis and treatment using microarray dataset and bioinformatics methods |
Basavaraj Vastrad, Chanabasayya Vastrad, Anandkumar Tengli |
| 21 |
[GO] |
2020―Aug―17 |
Investigation on the impacts of COVID-19 quarantine on society and environment: Preventive measures and supportive technologies |
Santhosh Kumar Kumaravel, Ranjith Kumar Subramani, Tharun Kumar Jayaraj Sivakumar, Rajvikram Madurai Elavarasan, Ajayragavan Manavalanagar Vetrichelvan, Annapurna Annam, Umashankar Subramaniam |
| 22 |
[GO] |
2020―Aug―11 |
Biosensors: frontiers in rapid detection of COVID-19 |
Rachel Samson, Govinda R. Navale, Mahesh S. Dharne |
